** Shares of Drugmaker Athenex Inc ATNX.O down 49.1% at
$0.58 before the bell
** Co and some of its units voluntarily file for Chapter 11
proceedings
**Co reaches an agreement with lenders to move forward with
an expedited sale process of its assets
** Assets to be sold across its primary businesses of
Athenex Pharmaceutical Division (APD), Orascovery, and Cell
Therapy.
** Says APD continues to operate during the sale process
with the inventory on hand
** Co has estimated assets and liabilities within $100 mln
-$500 mln, according to a filing with the U.S. Bankruptcy Court
for the Southern District of Texas
** Up to last close, stock has fallen 61.36% YTD
(Reporting by Raechel Thankam Job)
((RaechelThankam.Job@thomsonreuters.com;))